Feed 068270.KS
06

Celltrion, Inc. 068270.KS KSC · Healthcare · South Korea

₩213,500.00 +2.89% +₩6,000.00

Market cap
₩47.3T
Enterprise value
₩50.1T
P/E
35.8x
Forward P/E
32.8x
PEG
0.3x
P/S
8.7x
P/FCF
66.5x
EV/EBITDA
25.2x
ROIC
7.0%
Gross margin
43.1%
Net margin
24.3%
Dividend yield
0.34%
Payout ratio
12.3%
Net debt/EBITDA
1.4x
Beta
0.32
Free float
69.6%

Sector

Healthcare

Industry

Biotechnology

CEO

Woo-Sung Kee

Employees

3,153

Headquarters

Incheon

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Revenue grew by 22% a year over the last 3 years.
  • What speaks for it: Analysts expect revenue to grow by 38% this fiscal year.
  • What to watch: It missed profit estimates 5 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 KRW of revenue, 24 KRW is left as net profit.

Financial health

Can it carry its debt?

  • What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy